Over decades, researchers in the US government and programs it sponsored built up a tremendous number of climate resources, from comprehensive analyses to massive datasets to basic explainers meant to inform the public. And people within the government built the climate.gov website to make it all accessible. But if you try to navigate there today, you get redirected to the climate page of the National Oceanic and Atmospheric Administration, and are greeted with the following message:

In compliance with Executive Order 14303 (“Restoring Gold Standard Science”), the White House Office of Science and Technology Policy’s June 23, 2025 Memorandum (“Agency Guidance for Implementing Gold Standard Science in the Conduct & Management of Scientific Activities”), 15 USC § 2904 (“National Climate Program”), 15 USC § 2934 (“National Global Change Research Plan”), and 33 USC § 893a (“NOAA Ocean and Atmospheric Science Education Programs”), you have been redirected to NOAA.gov. Future research products previously housed under Climate.gov will be available at NOAA.gov/climate and its affiliate websites.

Climate.gov was essentially gone, and the team that deleted implied that it happened because climate research somehow failed to uphold what the administration was calling "gold standard science."

But the people who put together climate.gov didn't go away. While the government didn't hesitate to delete inconvenient climate information, dedicated volunteers outside the government managed to preserve copies of much of the material, which the federal government is prohibited from copyrighting. The volunteers and former climate.gov admins got together and launched climate.us. On Tuesday, the team announced that it had completed the project to restore everything lost when climate.gov shut down.

Read full article

Comments

In an extremely odd case, a single 79-year-old patient was granted early access to Eli Lilly's powerful, still-experimental obesity drug retatrutide through the Food and Drug Administration's "compassionate use" program—raising immediate questions if that sole patient is President Donald Trump, according to a report by Stat News.

Lilly's retatrutide is a highly anticipated next-generation obesity drug that targets GIP and glucagon hormones in addition to GLP-1. It is currently in late-stage trials to treat obesity, diabetes, sleep apnea, and other conditions. Data from a Phase 3 trial that Lilly released in May indicates that patients with obesity (but without diabetes) who took the drug for 80 weeks lost 28 percent of their weight, an amount comparable to bariatric surgery.

Millions of Americans with obesity are eager to get the drug, with options being limited so far to enrolling in a clinical trial or trying to obtain it by dodgy methods.

Read full article

Comments

An elderly Texas woman tragically died Friday after a man who told police he was relying on his Tesla Model 3’s automated driver-assistance mode lost control and crashed his car into her family’s home.

In a statement, the Harris County Sheriff’s Office confirmed to Ars that Michael Butler said that “he was operating with an automated driving-assistance system engaged at the time of the crash.” Police are currently investigating whether the autopilot feature in any way caused the crash but confirmed that Butler was not intoxicated and is cooperating, partly by helping cops understand how Tesla’s Autopilot feature works.

“Butler failed to drive in a single lane, left the roadway, and struck the residence” at a “high rate of speed,” the sheriff’s office said.

Read full article

Comments

In May, the federal government announced without warning that it would take apart a network of ocean monitoring systems that it had spent over $350 million to build. No reason was given for the decision to shut down the Ocean Observatories Initiative (OOI), but suspicion immediately focused on the network's role in tracking climate change.

But the OOI also provides data that's useful for weather forecasting and fisheries management, leading to widespread opposition. Today, it appears that the opposition has won, as the government will announce that it's reversing the decision. The big remaining question is how much damage the OOI took during the intervening month.

As of now, there is no formal statement available from the federal government. However, The New York Times reports that the decision will be announced later today, and Ars received a statement from Zoe Lofgren, the ranking Democrat on the House Science Committee, indicating that the decision has been made.

Read full article

Comments

Bernie Sanders has unveiled an aggressive plan to transfer trillions from leading AI firms to the public, and, to the likely horror of AI firms, it goes even further than expected to give Americans more control over the AI industry.

Sanders shared a summary of his legislation with AP News. If passed, the law would create a sovereign wealth fund “financed through a one-time 50 percent tax on the stock of the largest AI companies,” AP News reported. Any AI firm that does $200 million in annual AI sales would be subject to the tax, as would any new firm once it reaches that revenue level.

In total, Sanders estimated the fund could be worth $7 trillion, generating “hundreds of billions of dollars annually in direct payments to Americans and programs such as health care, education and housing,” AP News reported. Each American would likely receive more than $1,000 annually in 5 percent annual dividends, Sanders estimated.

Read full article

Comments

Amid intense backlash, the head of the American Diabetes Association posted a video Wednesday apologizing for the organization's decision on Friday to forcefully remove five leading diabetes scientists from the association's annual meeting.

The scientists were ejected for handing out copies of an April editorial—published in the ADA's own journal Diabetes Care—that sharply criticizes the Trump administration for the damage and destruction it's wreaking on biomedical research. The five scientists included Steven Kahn, professor of medicine at the University of Washington, who is the editor-in-chief of Diabetes Care and a co-author of the editorial. It also included former ADA President Desmond Schatz of the University of Florida.

The scientists were distributing the editorial outside the conference's opening speech, which was originally scheduled to be given by Jay Bhattacharya, head of the National Institutes of Health under Trump. Bhattacharya canceled at the last minute, and senior NIH official Rick Woychik took his place.

Read full article

Comments

On Thursday, President Donald Trump announced his administration's latest attempt to prop up the US coal industry during an incoherent press event that randomly oscillated between energy issues and Trump's fixation with building and renovating monuments in DC. The energy portion of the events was also frequently disconnected from reality.

"Today we're taking historic action to bring down the price of energy and the cost of living for all Americans with the power of clean, beautiful coal," said Trump, apparently unaware that coal is one of the most expensive means of generating electricity in the US.

With wind and solar power getting cheaper, coal has become the second-most expensive way of producing electricity, trailing only the cost of building a new nuclear plant. As a result, no new coal plants have been completed in over a decade, and coal has gone from powering over half the electrical grid to producing only about 15 percent of the nation's electricity. That's before the indirect costs of coal use are considered. It produces the most greenhouse gas emissions per unit of energy, releases dangerous particulates and chemicals into the atmosphere, and leaves behind ash that has high levels of toxic metals.

Read full article

Comments